Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

NCT04626973 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

3048

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Ezetimibe/Statin Combination therarpy (ezetimibe plus rosuvastatin)
DRUG: Statin monotherapy (rosuvastatin or atorvastatin)
DRUG: Ezetimibe/Statin Combination therarpy (ezetimibe plus rosuvastatin)
DRUG: Statin monotherapy (rosuvastatin or atorvastatin)

Sponsor

Yonsei University